Modelling the long-term benefits of tolvaptan therapy on renal function decline in autosomal dominant polycystic kidney disease: an exploratory analysis using the ADPKD outcomes model

Overview of attention for article published in BMC Nephrology, April 2019

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (81st percentile)
High Attention Score compared to outputs of the same age and source (82nd percentile)

Mentioned by

news: 1 news outlet

twitter: 2 X users

Citations

dimensions_citation: 15 Dimensions

Readers on

mendeley: 58 Mendeley

Summary News X Dimensions citations

So far, Altmetric has seen 1 news story.

ADPKD: Three Studies Provide New Insights

Medical Health News, 16 Jul 2019

Point on Tablet Researchers recently reported studies on autosomal-dominant polycystic disease (ADPKD).

This page shows the most recent news stories that mention this research output.

Click here to find out how to access more activity.